Respiratory Medicine
Volume 102, Issue 12 , Pages 1675-1680 , December 2008

Pulmonary rehabilitation in idiopathic pulmonary fibrosis: A call for continued investigation

  • Jeffrey J. Swigris

      Affiliations

    • Autoimmune Lung Center, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 303 398 1621; fax: +1 303 398 1040.
  • ,
  • Kevin K. Brown

      Affiliations

    • Autoimmune Lung Center, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA
  • ,
  • Barry J. Make

      Affiliations

    • COPD Program, National Jewish Medical and Research Center, Denver, CO, USA
  • ,
  • Frederick S. Wamboldt

      Affiliations

    • Division of Psychosocial Medicine, National Jewish Medical and Research Center, Denver, CO, USA

Received 28 May 2008 ,Accepted 24 August 2008.

References 

  1. Joint Statement of the American Thoracic Society and the European Respiratory Society . Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med. 2000;161:646–664
  2. Bjoraker JA, Ryu JH, Edwin MK, Meyers J, Tazelaar H, Schroeder D, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157:199–203
  3. Flaherty KR, Thwaite E, Kazerooni EA, Gross B, Toews GB, Colby TV, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003;58:143–148
  4. Swigris JJ, Stewart AL, Gould MK, Wilson SR. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005;3:61
  5. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005;142:963–967
  6. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?. Respir Med. 2005;99:408–414
  7. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest. 1996;109:1566–1576
  8. Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;143:219–225
  9. De Vries J, Kessels B, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J. 2001;17:954–961
  10. Naji NA, Connor MC, Donnelly SC, McDonnell TJ. Effectiveness of pulmonary rehabilitation in restrictive lung disease. J Cardiopulm Rehabil. 2006;26:237–243
  11. Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med. 2005;16:105–112
  12. Martinez J, Martinez T, Galhardo F, Pereira C. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Monit. 2002;8:CR405–CR410
  13. Martinez T, Pereira C, dos Santos M, Ciconelli R, Guimaraes S, Martinez J. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest. 2000;117:1627–1632
  14. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax. 2005;60:588–594
  15. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413
  16. Johnson BD, Weisman IM, Zeballos RJ, Beck KC. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest. 1999;116:488–503
  17. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770–777
  18. Aliverti A, Stevenson N, Dellaca RL, Lo Mauro A, Pedotti A, Calverley PM. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax. 2004;59:210–216
  19. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147:1151–1156
  20. Mador MJ, Bozkanat E, Kufel TJ. Quadriceps fatigue after cycle exercise in patients with COPD compared with healthy control subjects. Chest. 2003;123:1104–1111
  21. Bianchi R, Gigliotti F, Romagnoli I, Lanini B, Castellani C, Grazzini M, et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest. 2004;125:459–465
  22. Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Berube C, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:896–901
  23. Mador MJ, Kufel TJ, Pineda LA, Steinwald A, Aggarwal A, Upadhyay AM, et al. Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise. Am J Respir Crit Care Med. 2001;163:930–935
  24. Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore). 1978;57:545–560
  25. Emery CF, Leatherman NE, Burker EJ, MacIntyre NR. Psychological outcomes of a pulmonary rehabilitation program. Chest. 1991;100:613–617
  26. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998;17:232–240
  27. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003;65:963–970
  28. Aydin IO, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry. 2001;23:77–83
  29. Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest. 1985;87:35–38
  30. Stickland M, MacDonald G, Jendzjowsky N, Wong E, da Costa B, Stollery D. Improved health outcomes from pulmonary rehabilitation in patients with interstitial lung disease. Am J Respir Crit Care Med. 2008;177:A792
  31. Jacobs S, Hunter T, Rosen G, Mohabir P. Pulmonary rehabilitation outcomes for patients referred from an interstitial lung disease clinic. Am J Respir Crit Care Med. 2007;175:
  32. Whelan T, Ramchandani L, Kim H. Effect of pulmonary rehabilitation on six minute walk test in a well defined cohort of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;175:A497
  33. Shariat C, Garvey C, Rigler J, Collard HR. Pulmonary rehabilitation improves functional capacity in patients with interstitial lung disease. Chest. 2007;132:458
  34. Varadi R, Goldstein R, Stanbrook M. Outcomes of pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF). Am J Respir Crit Care Med. 2008;177:A792
  35. Patil S, Khoja S, Dholakia H, Javle H, Chowgule R. Effect of combined aerobic & resistance training exercise program on quality of life (QOL) & functional capacity in patients with healed tuberculosis (TB) & interstitial lung disease (ILD). Am J Respir Crit Care Med. 2008;177:A1000
  36. Jastrzebski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006;57(Suppl. 4):139–148
  37. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63:549–554
  38. Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13:394–399
  39. Haas F, Salazar-Schicchi J, Axen K. Desensitization to dyspnea in chronic obstructive pulmonary disease. In:  Casaburi R,  Petty T editor. Principles and practice of pulmonary rehabilitation. Philadelphia: Saunders; 1993;p. 241–251
  40. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–2073

 The work in this manuscript is the original work of the stated authors.

PII: S0954-6111(08)00312-0

doi: 10.1016/j.rmed.2008.08.014

Respiratory Medicine
Volume 102, Issue 12 , Pages 1675-1680 , December 2008